Australia's expedited plan to start dishing out COVID jabs in mid-late February will call for NASA-like logistical organisation. And ideally, no more clusters of infections to distract frontline workers.
Academic rigor, journalistic flair
Articles on Cold chain
Displaying all articles
So far, the only COVID-19 vaccines authorized for use need to be kept frozen. But there are many places in the world that can't support a cold supply chain.
COVID-19 vaccines have very specific storage requirements that make shipping a difficult task. Two ideas – fulfillment centers and cross-docking – could help overcome some distribution challenges.
A pharmaceutical supply chain expert explains the challenges of distributing the COVID-19 vaccines from Pfizer and Moderna that need to be kept at very low temperatures.
There are two new COVID-19 vaccines that appear to be more than 90% effective. But what are these vaccines, and how are they different from those used previously?
The Pfizer/BioNTech vaccine needs to be stored at -80⁰C.
The cold supply chain keeps vaccines fresh during distribution, but the current system is nowhere near large enough to distribute the billions of COVID-19 vaccines that the world needs.
A new way of getting functioning vaccines to where they are needed.
Inspired by amber and hard candy, researchers figured out a new, needle-free, shelf-stable way to preserve vaccines, making them easier to ship and administer around the world.
Vaccines need to be kept cold to remain effective. A lack of power in remote areas makes this difficult, reducing the reach of the life-saving pharmaceuticals.
Running an effective mass immunisation campaign, vaccinating children in Nigeria against measles is a logistical nightmare.
Top contributors
-
Senior Research Fellow in Global Health, University of Southampton
-
Professor of Pharmacy, University of Tasmania
-
Associate professor, University of Canberra
-
Senior Honorary Lecturer on Infectious Diseases, UCL
-
Lecturer in Chemistry, University of Bath
-
Professor of Epidemiology Healthcare Infection and Infectious Diseases Control, UNSW
-
John F. Smith Memorial Professor of Operations Management, University of Massachusetts Amherst
-
Assistant Professor of Pharmacy, University of Canberra
-
Head of Pharmacy (2013-present), University of Canberra
-
Professor in the faculty of Medicine, Mbarara University of Science and Technology
-
Postdoctoral Research Associate, University of Bath
-
Professor of Pharmaceutics, University of Texas at Austin
-
Project Coordinator & Staff Scientist, Vanderbilt University Medical Center, Vanderbilt University
-
Associate Professor of Operations Management & Business Analytics, Johns Hopkins Carey Business School, Johns Hopkins University School of Nursing
-
Professor of Environmental Conservation, University of Massachusetts Amherst
